Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
44,582,122
-
Share change
-
+7,948,324
-
Total reported value
-
$3,090,994,782
-
Put/Call ratio
-
181%
-
Price per share
-
$69.34
-
Number of holders
-
293
-
Value change
-
+$589,775,116
-
Number of buys
-
161
-
Number of sells
-
126
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q1 2017
As of 31 Mar 2017,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
293 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,582,122 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, CITIGROUP INC, BNP PARIBAS ARBITRAGE, SA, UBS Group AG, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, STATE OF WISCONSIN INVESTMENT BOARD, WELLS FARGO & COMPANY/MN, and ASSETMARK, INC.
This page lists
293
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.